Skip to content

Effect of scleral lens on refractory dry eye and irregular corneal astigmatism

Effect of scleral lens on refractory dry eye and irregular corneal astigmatism

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056257
Enrollment
Unknown
Registered
2022-02-03
Start date
2022-02-03
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory dry eye and irregular corneal astigmatism

Interventions

Group :Scleral lens

Sponsors

Hankou Aier EYE Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 86 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18-86; 2. Refractory dry eye and irregular corneal astigmatism; 3. The visual acuity of the naked eye is better than that of the digital finger; 4. Best corrected visual acuity >= 0.5; 5. The subjects understood the study requirements and treatment process, and provided written informed consent before any examination or treatment for the study.

Exclusion criteria

Exclusion criteria: 1. Infectious keratitis is currently being treated; 2. Severe allergic conjunctivitis, low compliance and other potential contraindications lead to difficulties in the application of scleral endoscopy; 3. Diseases that affect sensory sensitivity (herpes disease, severe diabetes); 4. The anatomical variation of conjunctiva affects the correct wearing of the scleral mirror; 5. Pregnancy; 6. Other eye diseases other than dry eye (such as glaucoma and age-related macular degeneration) may have a significant impact on visual function; 7. Any other circumstances that the investigator believes expose the patient to excessive risk.

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity;Tear break-up time;

Secondary

MeasureTime frame
Intraocular pressure;

Countries

China

Contacts

Public ContactZeng Qingyan

Hankou Aier EYE Hospital

zengqingyan1972@163.com+86 13971009610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026